172 related articles for article (PubMed ID: 35774066)
1. Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing.
Tran MY; Kamen AA
Front Bioeng Biotechnol; 2022; 10():887716. PubMed ID: 35774066
[TBL] [Abstract][Full Text] [Related]
2. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
3. Development of a perfusion process for continuous lentivirus production using stable suspension producer cell lines.
Klimpel M; Terrao M; Ching N; Climenti V; Noll T; Pirzas V; Laux H
Biotechnol Bioeng; 2023 Sep; 120(9):2622-2638. PubMed ID: 37148430
[TBL] [Abstract][Full Text] [Related]
4. Process intensification for lentiviral vector manufacturing using tangential flow depth filtration.
Tona RM; Shah R; Middaugh K; Steve J; Marques J; Roszell BR; Jung C
Mol Ther Methods Clin Dev; 2023 Jun; 29():93-107. PubMed ID: 36994313
[TBL] [Abstract][Full Text] [Related]
5. Generation of stable suspension producer cell lines for serum-free lentivirus production.
Klimpel M; Terrao M; Bräuer M; Dersch H; Biserni M; Melo Do Nascimento L; Schwingal S; Vogel JE; Ferlemann C; Brandt T; Lal NI; Bridgeman K; Petzke A; McDwyer E; Lim JL; Oh S; Brumatti G; Garcia Minambres A; Otte E; Noll T; Pirzas V; Laux H
Biotechnol J; 2024 May; 19(5):e2400090. PubMed ID: 38719592
[TBL] [Abstract][Full Text] [Related]
6. Quasi-perfusion studies for intensified lentiviral vector production using a continuous stable producer cell line.
Stibbs DJ; Silva Couto P; Takeuchi Y; Rafiq QA; Jackson NB; Rayat ACME
Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101264. PubMed ID: 38827249
[TBL] [Abstract][Full Text] [Related]
7. Continuous manufacturing of lentiviral vectors using a stable producer cell line in a fixed-bed bioreactor.
Stibbs DJ; Silva Couto P; Takeuchi Y; Rafiq QA; Jackson NB; Rayat ACME
Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101209. PubMed ID: 38435128
[TBL] [Abstract][Full Text] [Related]
8. Development of Large-Scale Downstream Processing for Lentiviral Vectors.
Valkama AJ; Oruetxebarria I; Lipponen EM; Leinonen HM; Käyhty P; Hynynen H; Turkki V; Malinen J; Miinalainen T; Heikura T; Parker NR; Ylä-Herttuala S; Lesch HP
Mol Ther Methods Clin Dev; 2020 Jun; 17():717-730. PubMed ID: 32346549
[TBL] [Abstract][Full Text] [Related]
9. Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration.
Göbel S; Pelz L; Silva CAT; Brühlmann B; Hill C; Altomonte J; Kamen A; Reichl U; Genzel Y
Appl Microbiol Biotechnol; 2024 Feb; 108(1):240. PubMed ID: 38413399
[TBL] [Abstract][Full Text] [Related]
10. Depth filtration for clarification of intensified lentiviral vector suspension cell culture.
Mayani M; Nellimarla S; Mangalathillam R; Rao H; Patarroyo-White S; Ma J; Figueroa B
Biotechnol Prog; 2024; 40(2):e3409. PubMed ID: 37985144
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral Vector Bioprocessing.
Perry C; Rayat ACME
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572347
[TBL] [Abstract][Full Text] [Related]
12. Rapid Lentiviral Vector Producer Cell Line Generation Using a Single DNA Construct.
Chen YH; Pallant C; Sampson CJ; Boiti A; Johnson S; Brazauskas P; Hardwicke P; Marongiu M; Marinova VM; Carmo M; Sweeney NP; Richard A; Shillings A; Archibald P; Puschmann E; Mouzon B; Grose D; Mendez-Tavio M; Chen MX; Warr SRC; Senussi T; Carter PS; Baker S; Jung C; Brugman MH; Howe SJ; Vink CA
Mol Ther Methods Clin Dev; 2020 Dec; 19():47-57. PubMed ID: 32995359
[TBL] [Abstract][Full Text] [Related]
13. Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy.
Tang QL; Gu LX; Xu Y; Liao XH; Zhou Y; Zhang TC
Bioengineered; 2021 Dec; 12(1):2095-2105. PubMed ID: 34047682
[TBL] [Abstract][Full Text] [Related]
14. Large-scale production means for the manufacturing of lentiviral vectors.
Schweizer M; Merten OW
Curr Gene Ther; 2010 Dec; 10(6):474-86. PubMed ID: 21054245
[TBL] [Abstract][Full Text] [Related]
15. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
16. Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media.
Bauler M; Roberts JK; Wu CC; Fan B; Ferrara F; Yip BH; Diao S; Kim YI; Moore J; Zhou S; Wielgosz MM; Ryu B; Throm RE
Mol Ther Methods Clin Dev; 2020 Jun; 17():58-68. PubMed ID: 31890741
[TBL] [Abstract][Full Text] [Related]
17. Transient Lentiviral Vector Production Using a Packed-Bed Bioreactor System.
McCarron A; Donnelley M; McIntyre C; Parsons D
Hum Gene Ther Methods; 2019 Jun; 30(3):93-101. PubMed ID: 31084376
[TBL] [Abstract][Full Text] [Related]
18. AAV process intensification by perfusion bioreaction and integrated clarification.
Mendes JP; Fernandes B; Pineda E; Kudugunti S; Bransby M; Gantier R; Peixoto C; Alves PM; Roldão A; Silva RJS
Front Bioeng Biotechnol; 2022; 10():1020174. PubMed ID: 36420444
[TBL] [Abstract][Full Text] [Related]
19. Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.
Venereo-Sanchez A; Simoneau M; Lanthier S; Chahal P; Bourget L; Ansorge S; Gilbert R; Henry O; Kamen A
Vaccine; 2017 Jul; 35(33):4220-4228. PubMed ID: 28648546
[TBL] [Abstract][Full Text] [Related]
20. Construction of stable producer cells to make high-titer lentiviral vectors for dendritic cell-based vaccination.
Lee CL; Chou M; Dai B; Xiao L; Wang P
Biotechnol Bioeng; 2012 Jun; 109(6):1551-60. PubMed ID: 22179950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
